Li Wan
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanocomposite Films for Food Packaging
Papers in ⓘ
-
- Pharmacological Effects of Natural Compounds 5
- Piperaceae Chemical and Biological Studies 3
-
- Traditional Chinese Medicine Analysis 6
- Co-authors
- Xiangjin Zheng (1 shared paper)Sha Li (1 shared paper)Liwen Ren (1 shared paper)Guanhua Du (1 shared paper)Yihui Yang (1 shared paper)Jinhua Wang (1 shared paper)Weiqi Fu (1 shared paper)Jie Yi (1 shared paper)
- Journals
- International Journal of Biological Macromolecules (3 papers)Journal of Ethnopharmacology (3 papers)Molecules (2 papers)ACS Applied Materials & Interfaces (2 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Li Wan
47 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 282
- Biomaterials 149
- Molecular Biology 593
- Complementary and alternative medicine 53
- Biochemistry 38
Countries citing papers authored by Li Wan
This map shows the geographic impact of Li Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Wan more than expected).
Fields of papers citing papers by Li Wan
This network shows the impact of papers produced by Li Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Wan. The network helps show where Li Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The biology, function, and applications of exosomes in cancer Hit paper breakdown → | 2021 | 395 |
| 2 | The strategies and techniques of drug discovery from natural products Hit paper breakdown → | 2020 | 193 |
| 3 | 2019 | 110 | |
| 4 | 2021 | 44 | |
| 5 | 2022 | 39 | |
| 6 | 2014 | 36 | |
| 7 | 2022 | 32 | |
| 8 | 2021 | 31 | |
| 9 | 2018 | 30 | |
| 10 | 2016 | 23 | |
| 11 | 2012 | 20 | |
| 12 | 2024 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2024 | 12 | |
| 15 | 2024 | 11 | |
| 16 | 2024 | 11 | |
| 17 | 2024 | 11 | |
| 18 | 2020 | 10 | |
| 19 | 2023 | 9 | |
| 20 | 2024 | 9 |
About Li Wan
Li Wan is a scholar working on Pharmacology, Complementary and alternative medicine, Toxicology, Molecular Medicine and Pharmaceutical Science, having authored 49 papers that have together received 1.1k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (6 papers), Pharmacological Effects of Natural Compounds (5 papers), Natural product bioactivities and synthesis (4 papers), Thermal Radiation and Cooling Technologies (4 papers), Urban Heat Island Mitigation (4 papers), Nanoplatforms for cancer theranostics (3 papers), Piperaceae Chemical and Biological Studies (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Cancer Research (282 citations), Biomaterials (149 citations), Molecular Biology (593 citations), Complementary and alternative medicine (53 citations) and Biochemistry (38 citations). Li Wan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiangjin Zheng, Sha Li, Liwen Ren, Guanhua Du, Yihui Yang, Jinhua Wang, Weiqi Fu, Jie Yi, Jinyi Liu and Yang Lü. Their work appears in journals such as International Journal of Biological Macromolecules, Journal of Ethnopharmacology, Molecules, ACS Applied Materials & Interfaces and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.